Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapy

被引：5
|
作者：
Elstein, Deborah [1 ]
Abrahamov, Ayala
Altarescu, Gheona
Zimran, Ari
机构：
[1] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
来源：
BLOOD CELLS MOLECULES AND DISEASES | 2013年 / 50卷 / 02期
关键词：
D O I：
10.1016/j.bcmd.2012.09.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [31] Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3
    Hoj, Astrid
    Orngreen, Mette Cathrine
    Naume, Marie Mostue
    Lund, Allan Meldgaard
    MOLECULAR GENETICS AND METABOLISM, 2024, 142 (04)
  • [32] Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy
    Cox, Timothy M.
    Drelichman, Guillermo
    Cravo, Renata
    Balwani, Manisha
    Burrow, Thomas Andrew
    Martins, Ana Maria
    Lukina, Elena
    Rosenbloom, Barry
    Goker-Alpan, Ozlem
    Watman, Nora
    El-Beshlawy, Amal
    Kishnani, Priya S.
    Pedroso, Maria Lucia
    Gaemers, Sebastiaan J. M.
    Tayag, Regina
    Peterschmitt, M. Judith
    BLOOD, 2017, 129 (17) : 2375 - 2383
  • [33] An infant with type II Gaucher disease treated with enzyme replacement therapy
    Ebihara, Go
    Matsushita, Yuki
    Kirino, Makiko
    Hikino, Shunji
    Sato, Kazuo
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [34] Long-term safety and efficacy of enzyme replacement therapy for Fabry disease
    Wilcox, WR
    Banikazemi, M
    Guffon, N
    Waldek, S
    Lee, P
    Linthorst, GE
    Desnick, RJ
    Germain, DP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (01) : 65 - 74
  • [35] Evaluation of long-term enzyme replacement therapy for children with Fabry disease
    Hebert, Amanda
    Lacbawan, Ley
    Taber, Tabitha
    Goker-Alpan, Ozlem
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S47 - S47
  • [36] Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature
    Kabacam, Gokhan
    Kabacam, Gulsah
    Topcuoglu, Pervin
    Kuzu, Isinsu
    Arat, Mutlu
    TURKISH JOURNAL OF HEMATOLOGY, 2010, 27 (03) : 190 - 195
  • [37] Impact of long-term enzyme replacement therapy on Lyso-Gb1 in patients with Gaucher disease: Comparison between 3 enzymatic formulations
    Dinur, Tama
    Grittner, Ulrike
    Becker-Cohen, Michal
    Istaiti, Majdolen
    Cozma, Claudia
    Rolfs, Arndt
    Revel-Vilk, Shoshana
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S34 - S35
  • [38] Long-term efficacy and safety of enzyme replacement therapy in Fabry disease
    Germain, DP
    Caplan, L
    Eng, CM
    Guffon, N
    Lee, P
    Linthorst, G
    Waldeck, S
    Wilcox, WR
    Desnick, RJ
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 70 - 70
  • [39] Enzyme replacement therapy in adult patients with type I Gaucher disease
    Ponomarev, R., V
    Lukina, E. A.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (07) : 127 - 131
  • [40] ADULT-TYPE GAUCHER DISEASE IN CHILDREN - GENETICS, CLINICAL-FEATURES AND ENZYME REPLACEMENT THERAPY
    ZEVIN, S
    ABRAHAMOV, A
    HADASHALPERN, I
    KANNAI, R
    LEVYLAHAD, E
    HOROWITZ, M
    ZIMRAN, A
    QUARTERLY JOURNAL OF MEDICINE, 1993, 86 (09): : 565 - 573
12345